Seattle Cancer Care Alliance; Investigational Drug Service — Seattle, Washington

Seattle Cancer Care Alliance; Investigational Drug Service is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Seattle Cancer Care Alliance; Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seattle Cancer Care Alliance; Investigational Drug Service?

Seattle Cancer Care Alliance; Investigational Drug Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seattle Cancer Care Alliance; Investigational Drug Service conducted?

Seattle Cancer Care Alliance; Investigational Drug Service has 1 clinical trials on record. Their work covers Glioblastoma.

Is Seattle Cancer Care Alliance; Investigational Drug Service accredited by Crixeo Health?

Seattle Cancer Care Alliance; Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seattle Cancer Care Alliance; Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.